Hologic (HOLX) Competitors $54.82 -1.65 (-2.92%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$55.43 +0.61 (+1.12%) As of 05/21/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. BDX, EW, IDXX, RMD, DXCM, STE, PODD, BAX, MASI, and GMEDShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry. Hologic vs. Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Masimo Globus Medical Hologic (NASDAQ:HOLX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Does the media favor HOLX or BDX? In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Hologic. MarketBeat recorded 34 mentions for Becton, Dickinson and Company and 12 mentions for Hologic. Becton, Dickinson and Company's average media sentiment score of 1.43 beat Hologic's score of 1.33 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 29 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate HOLX or BDX? Hologic currently has a consensus price target of $77.42, suggesting a potential upside of 41.22%. Becton, Dickinson and Company has a consensus price target of $231.44, suggesting a potential upside of 33.59%. Given Hologic's higher probable upside, research analysts plainly believe Hologic is more favorable than Becton, Dickinson and Company.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.41Becton, Dickinson and Company 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Which has higher earnings & valuation, HOLX or BDX? Becton, Dickinson and Company has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.03$789.50M$2.3723.13Becton, Dickinson and Company$20.87B2.38$1.71B$5.2433.06 Is HOLX or BDX more profitable? Hologic has a net margin of 18.42% compared to Becton, Dickinson and Company's net margin of 8.47%. Hologic's return on equity of 19.72% beat Becton, Dickinson and Company's return on equity.Company Net Margins Return on Equity Return on Assets Hologic18.42% 19.72% 10.94% Becton, Dickinson and Company 8.47%15.74%7.29% Which has more volatility and risk, HOLX or BDX? Hologic has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Does the MarketBeat Community believe in HOLX or BDX? Hologic received 277 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 69.09% of users gave Hologic an outperform vote while only 62.09% of users gave Becton, Dickinson and Company an outperform vote. CompanyUnderperformOutperformHologicOutperform Votes88369.09% Underperform Votes39530.91% Becton, Dickinson and CompanyOutperform Votes60662.09% Underperform Votes37037.91% Do institutionals & insiders have more ownership in HOLX or BDX? 94.7% of Hologic shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.9% of Hologic shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryHologic beats Becton, Dickinson and Company on 11 of the 18 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.22B$11.16B$5.37B$8.39BDividend YieldN/A1.66%5.22%4.10%P/E Ratio17.2916.6826.7719.71Price / Sales3.037.79393.17117.39Price / Cash11.6911.9038.2534.62Price / Book2.581.966.794.50Net Income$789.50M$344.53M$3.23B$248.18M7 Day Performance-1.65%-3.76%1.53%0.20%1 Month Performance-5.79%6.06%10.06%12.37%1 Year Performance-26.72%-7.72%16.74%7.04% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.956 of 5 stars$54.82-2.9%$77.42+41.2%-26.5%$12.22B$4.03B17.296,940Positive NewsBDXBecton, Dickinson and Company4.9833 of 5 stars$175.22+4.8%$231.44+32.1%-26.2%$50.22B$20.87B29.1177,000Positive NewsHigh Trading VolumeEWEdwards Lifesciences3.8862 of 5 stars$74.65+1.3%$79.45+6.4%-15.7%$43.88B$5.52B10.7117,300Positive NewsIDXXIDEXX Laboratories3.3927 of 5 stars$509.46+3.6%$524.75+3.0%-3.4%$40.97B$3.93B47.7510,800Positive NewsAnalyst ForecastRMDResMed4.1235 of 5 stars$247.71+1.1%$258.83+4.5%+12.5%$36.32B$5.02B29.258,160Positive NewsAnalyst RevisionDXCMDexCom4.7387 of 5 stars$84.99+0.4%$98.11+15.4%-35.1%$33.33B$4.15B59.447,600Positive NewsSTESTERIS4.5592 of 5 stars$232.89+2.9%$258.75+11.1%+6.8%$22.88B$5.40B49.4516,000News CoverageAnalyst ForecastPODDInsulet4.4316 of 5 stars$316.54+1.9%$303.81-4.0%+77.5%$22.27B$2.07B54.672,600Positive NewsBAXBaxter International4.6524 of 5 stars$31.88+3.2%$37.25+16.8%-11.7%$16.36B$10.77B-24.9160,000Gap UpMASIMasimo4.8463 of 5 stars$163.79+4.6%$191.60+17.0%+20.0%$8.88B$2.13B112.966,200GMEDGlobus Medical4.8894 of 5 stars$58.98+5.7%$94.00+59.4%-10.9%$8.11B$2.51B78.642,600Buyback AnnouncementHigh Trading Volume Related Companies and Tools Related Companies Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Masimo Alternatives Globus Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
